Reata Pharmaceuticals (NASDAQ: RETA) has appointed Manmeet Soni to serve as chief financial officer and executive vice president. With Soni’s hire, James Wilson, CFO and executive vice president of strategy, will shift to a new role as Reata’s executive vice president of operations. Soni stepped down as CFO of Alnylam Pharmaceuticals (NASDAQ: ALNY) last month. His experience also includes CFO posts at Ariad Pharmaceuticals and Pharmacyclics. Irving, TX-based Reata is developing drugs that target molecular pathways governing cellular metabolism and inflammation.